Oncology focusing on immunotherapy in lung cancer. The pharmacological management of lung cancer is
a rapidly evolving field with immunotherapy leading this era of change. Immunotherapy is a very exciting
topic and the mainstay of symposium topics at international conferences in lung cancer currently.
This MTOC symposium will focus on presenting the theory of immunotherapy and the journey of
immunotherapy in lung cancer, providing an insight into the challenges of PD1/PDL1 testing both in terms
of multiple methodologies and how testing in real-life, large scale practice might look like and review the
current immunotherapy trials open in the UK, phase 1-3, for lung cancer patients.
Read more details here